Merrimack Pharmaceuticals (MACK) Stock Chart & Stock Price History → Gold Mania (From Stansberry Research) (Ad) Free MACK Stock Alerts $15.00 -0.03 (-0.20%) (As of 05/3/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Merrimack Pharmaceuticals Stock Price Performance5 Day Performance+1.76%1 Month Performance+1.97%3 Month Performance+12.28%6 Month Performance+20.00%Year-To-Date Performance+11.86%1 Year Performance+17.92% Receive MACK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Merrimack Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Colonial MetalsThe asset beating inflation by 4x"Trump Loophole" Beats Inflation? Inflation has been out of control for years. Forcing you to work longer and harder for more money that is worth less. By using the "Trump Loophole", you can use a special retirement account to buy gold — and other precious metals — without taxes or penalties.That's why we have released our Free Precious Metals Investment Guide that explains all the details MACK Stock Chart for Sunday, May, 5, 2024 MACK Chart by TradingView Merrimack Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/03/2024$15.03$15.00-0.20%$15.03$15.00187,562 shs$217.95 million05/02/2024$14.98$15.03+0.33%$15.03$14.96207,080 shs$218.39 million05/01/2024$14.74$14.98+1.63%$14.99$14.94310,213 shs$217.66 million04/30/2024$14.74$14.74$14.77$14.7382,222 shs$214.17 million04/29/2024$14.73$14.74+0.07%$14.80$14.7295,058 shs$214.17 million04/26/2024$14.73$14.73$14.76$14.7155,162 shs$214.03 million Get the Latest News and Ratings for MACK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Merrimack Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/25/2024$14.71$14.73+0.14%$14.75$14.7082,841 shs$214.03 million04/24/2024$14.73$14.71-0.14%$14.77$14.71106,490 shs$213.74 million04/23/2024$14.73$14.73$14.78$14.7279,779 shs$214.03 million04/22/2024$14.72$14.73+0.07%$14.78$14.7195,000 shs$214.03 million04/19/2024$14.68$14.72+0.27%$14.73$14.6876,084 shs$213.88 million04/18/2024$14.68$14.68$14.71$14.67113,575 shs$213.30 million04/17/2024$14.68$14.68$14.71$14.67102,419 shs$213.30 million04/16/2024$14.68$14.68$14.70$14.66101,244 shs$213.30 million04/15/2024$14.68$14.68$14.73$14.67141,436 shs$213.30 million04/12/2024$14.73$14.68-0.34%$14.72$14.68109,432 shs$213.30 million04/11/2024$14.72$14.73+0.07%$14.75$14.7168,639 shs$214.03 million04/10/2024$14.73$14.72-0.07%$14.74$14.7192,910 shs$213.88 million04/09/2024$14.70$14.73+0.20%$14.75$14.7047,758 shs$214.06 million04/08/2024$14.71$14.70-0.07%$14.73$14.7097,061 shs$213.59 million04/05/2024$14.70$14.71+0.07%$14.78$14.70196,988 shs$213.74 million04/04/2024$14.71$14.70-0.07%$14.74$14.7082,348 shs$213.59 million04/03/2024$14.73$14.71-0.14%$14.75$14.7199,640 shs$213.74 million04/02/2024$14.74$14.73-0.07%$14.76$14.7090,872 shs$214.03 million04/01/2024$14.77$14.74-0.20%$14.82$14.74108,661 shs$214.17 million03/29/2024$14.77$14.77$14.85$14.75426,294 shs$214.64 million03/28/2024$14.75$14.77+0.14%$14.85$14.75413,038 shs$214.61 million03/27/2024$14.72$14.75+0.20%$14.80$14.7295,075 shs$214.32 million03/26/2024$14.73$14.72-0.07%$14.82$14.72103,473 shs$213.88 million03/25/2024$14.79$14.73-0.41%$14.91$14.7399,675 shs$214.03 million03/22/2024$14.69$14.79+0.68%$14.85$14.73193,562 shs$214.75 million03/21/2024$14.69$14.69$14.77$14.6989,846 shs$213.30 million03/20/2024$14.69$14.69$14.76$14.67106,498 shs$213.30 million03/19/2024$14.72$14.69-0.20%$14.77$14.6971,793 shs$213.30 million03/18/2024$14.74$14.72-0.14%$14.75$14.6891,728 shs$213.73 million03/15/2024$14.66$14.74+0.55%$14.76$14.64181,434 shs$214.03 million03/14/2024$14.69$14.66-0.20%$14.70$14.66101,749 shs$212.86 million03/13/2024$14.65$14.69+0.27%$14.72$14.64156,481 shs$213.30 million03/12/2024$14.66$14.65-0.07%$14.73$14.60117,220 shs$212.72 million03/11/2024$14.72$14.66-0.41%$14.74$14.6287,659 shs$212.86 millionForget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad)If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details03/08/2024$14.77$14.72-0.34%$14.83$14.7097,171 shs$210.79 million03/07/2024$14.71$14.77+0.41%$14.78$14.7077,974 shs$211.51 million03/06/2024$14.69$14.71+0.14%$14.73$14.6956,505 shs$210.65 million03/05/2024$14.69$14.69$14.75$14.6876,389 shs$210.38 million03/04/2024$14.74$14.69-0.34%$14.77$14.6990,896 shs$210.36 million03/01/2024$14.70$14.74+0.27%$14.78$14.6887,897 shs$211.08 million02/29/2024$14.70$14.70$14.78$14.6951,739 shs$210.50 million02/28/2024$14.71$14.70-0.07%$14.76$14.6840,213 shs$210.50 million02/27/2024$14.70$14.71+0.07%$14.79$14.6845,109 shs$210.65 million02/26/2024$14.73$14.70-0.20%$14.80$14.6769,663 shs$210.50 million02/23/2024$14.72$14.73+0.07%$14.80$14.6666,315 shs$210.93 million02/22/2024$14.68$14.72+0.27%$14.75$14.6565,170 shs$210.79 million02/21/2024$14.70$14.68-0.14%$14.78$14.61127,502 shs$210.22 million02/20/2024$14.70$14.70$14.74$14.64185,138 shs$210.52 million02/19/2024$14.70$14.70$14.80$14.67239,900 shs$210.50 million02/16/2024$14.70$14.70$14.80$14.67239,938 shs$210.50 million02/15/2024$14.67$14.70+0.20%$14.80$14.62228,827 shs$210.52 million02/14/2024$15.00$14.67-2.20%$14.80$14.53701,628 shs$210.07 million02/13/2024$13.99$15.00+7.22%$15.89$13.601.27 million shs$214.80 million02/12/2024$13.80$13.99+1.38%$14.21$13.72118,954 shs$200.34 million02/09/2024$13.62$13.80+1.32%$13.85$13.34115,062 shs$197.62 million02/08/2024$13.06$13.62+4.29%$13.70$12.9484,793 shs$195.04 million02/07/2024$13.25$13.06-1.43%$13.25$13.0269,337 shs$187.02 million02/06/2024$13.36$13.25-0.82%$13.49$12.9775,139 shs$189.74 million02/05/2024$13.13$13.36+1.75%$13.39$13.00108,677 shs$191.32 million Related Companies: RIGL Stock Price Chart VSTM Stock Price Chart VNDA Stock Price Chart RGLS Stock Price Chart XOMA Stock Price Chart EBS Stock Price Chart LXRX Stock Price Chart OPK Stock Price Chart OVID Stock Price Chart GALT Stock Price Chart Receive MACK Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Merrimack Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MACK) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe only AI company you should be looking atBehind the MarketsWarren Buffet Stockpiling Gold?Reagan Gold GroupDid You Get Your Free Bitcoin Yet?Crypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merrimack Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.